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Abstract
Collection of surveillance data is essential for monitoring and evaluation of public health pro-
grams. Integrated collection of household-based health data, now routinely carried out in
many countries through demographic health surveys and multiple indicator surveys, pro-
vides critical measures of progress in health delivery. In contrast, biomarker surveys typi-
cally focus on single or related measures of malaria infection, HIV status, vaccination
coverage, or immunity status for vaccine-preventable diseases (VPD). Here we describe an
integrated biomarker survey based on use of a multiplex bead assay (MBA) to simulta-
neously measure antibody responses to multiple parasitic diseases of public health impor-
tance as part of a VPD serological survey in Cambodia. A nationally-representative cluster-
based survey was used to collect serum samples from women of child-bearing age. Sam-
ples were tested by MBA for immunoglobulin G antibodies recognizing recombinant anti-
gens from Plasmodium falciparum and P. vivax,Wuchereria bancrofti, Toxoplasma gondii,
Taenia solium, and Strongyloides stercoralis. Serologic IgG antibody results were useful
both for generating national prevalence estimates for the parasitic diseases of interest and
for confirming the highly focal distributions of some of these infections. Integrated surveys
offer an opportunity to systematically assess the status of multiple public health programs
and measure progress toward Millennium Development Goals.
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Author Summary
In 2012 a comprehensive national serosurvey to assess immunity to vaccine preventable
diseases such as polio, rubella, measles, and tetanus was conducted among women of child
bearing age in Cambodia. We were able to test this sample set using a multiplex bead assay
in order to measure specific antibody responses to the parasites that cause malaria, toxo-
plasmosis, lymphatic filariasis, cysticercosis, and strongyloidiasis. National prevalence esti-
mates generated from the serologic data show widespread exposure (>45% positive) to the
soil transmitted nematode worm, Strongyloides stercoralis. In contrast,<5% of women
were positive for antibodies to P. falciparummalaria, P. vivaxmalaria, and lymphatic fila-
riasis, and antibody-positive women were mainly found in the North region of the coun-
try. Women who were positive for antibodies to Toxoplasma gondii and Taenia solium
(5.8% and 2.6% of the population, respectively) were not clustered in any particular geo-
graphic region. With this study we have shown how the integration of a multiplex assay
into a national serosurvey can provide useful information on the prevalence and distribu-
tions of medically important parasitic infections.
Introduction
In many tropical and sub-tropical countries, the disease burden represented by neglected tropi-
cal diseases (NTDs) is substantial, yet information on the prevalence and distribution of these
diseases is limited because of the significant costs associated with disease-specific surveys. Even
with the recent scale-up of preventive chemotherapy programs targeting NTDs [1], routine
assessments to monitor the impact of these programs, when they occur, are often restricted to
sentinel sites and may not be representative of all program areas. For some diseases such as
strongyloidiasis, prevalence data for many regions of the world are lacking, and no public
health strategy has been developed for control of the disease [2, 3].
Demographic and Health Surveys (DHS) and other population-based multiple indicator
surveys are conducted to assess the performance of health and development programs. The
United States Agency for International Development (USAID) has assisted in over 230 DHS
surveys in more than eighty countries since 1984 at a cost of approximately $380 million dol-
lars, and additional monies have been contributed by other donors as well as host countries [4].
Collection of biomarker data is often included in these types of population-based surveys to
assess morbidity, HIV status, or malaria infection prevalence, but these surveys have not been
extended to include NTDs. Multiplexing technologies provide new opportunities to collect
data on a large number of diseases using a single serum sample or dried blood spot [5]. Such an
approach would provide Ministries of Health with valuable information on the distribution
and prevalence of NTDs, opportunities to monitor the impact of NTD interventions, evidence
to inform programmatic decisions, and post-elimination surveillance.
The Cambodian Ministry of Health conducted a serological survey in 2012 to assess popula-
tion immunity for poliomyelitis, measles, rubella and tetanus among women aged 15–39 years
[6]. This comprehensive national serological survey provided an excellent opportunity to
gather information on the distribution and prevalence of other diseases throughout Cambodia
by measuring antibody responses to a panel of antigens representing several parasitic infec-
tions. We used multiplexing technology to assay sera collected in this national serological sur-
vey for immunoglobulin G (IgG) antibodies against tetanus, measles, Plasmodium falciparum
and P. vivax,Wuchereria bancrofti, Toxoplasma gondii, Taenia solium, Strongyloides stercoralis,
and several arthropod-borne viruses. For S. stercoralis the national prevalence exceeded 40%
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and was indicative of a country-wide public health problem of surprising magnitude. Multi-
plexed approaches provide an opportunity to gather information of public health importance




Samples were obtained during a serological survey in November and December 2012 as previ-
ously described [6]. Briefly, blood samples were collected from women of child-bearing age
(15–39 years) throughout Cambodia. Multi-stage cluster sampling was performed with over-
sampling of areas identified as higher risk for tetanus based on the 2009 Cambodian neonatal
tetanus risk assessment. One hundred enumeration areas (EAs) were selected by simple ran-
dom sampling of the 611 EAs defined for Cambodia’s 2010 DHS survey. The number of rural
and urban EAs from each region were selected to match the relative proportion of urban and
rural populations in the region. From each of the EAs, twenty-two households were selected
and all eligible women in those households were invited to participate. The design and sample
size were selected to provide estimates of population rubella and tetanus immunity nationwide
and by age-group [6, 7].
Five milliliters of whole blood were collected from each participant, and sera were separated
shortly thereafter and stored at -80°C. As previously described, samples were initially tested by
enzyme-linked immunosorbent assay (ELISA) or standard microneutralization assay for anti-
bodies to measles, rubella, and polio [6]. Residual samples were then tested by multiplex bead
assay (MBA) at CDC in Atlanta, GA, and by double antigen ELISA for tetanus antibody levels
at the Statens Serum Institut, Copenhagen, Denmark. The results of measles, rubella and polio
antibody testing have been published [3] and the tetanus assay results will be reported else-
where [7]. As previously described [7], a total of 2150 samples had reported tetanus values and
were included in the multiplex assay testing.
Ethics statement
Written informed consent was obtained and documented prior to participation in the survey;
specific consent for serologic testing of diseases of public health importance was included as
part of this process. Consent was also be obtained separately from the parent or guardian of
women under the age of 18. The protocol was reviewed and approved by the national ethics
committee in Cambodia.
Recombinant parasite antigens used
Staff of the Ministry of Health of Cambodia selected antigens to be included in the multiplex.
The following parasite-specific recombinant antigens were used in the MBA (Table 1): NIE for
Strongyloides stercoralis [8]; SAG2A for Toxoplasma gondii [9, 10]; T24H for cysticercosis [11];
PfMSP-119 (3D7 strain) and PfMSP-142 (3D7 strain and FVO strain) for P. falciparummalaria
[12, 13]; and PvMSP-119 (Belem strain) for P. vivaxmalaria [14, 15]. For lymphatic filariasis,
Brugia malayi Bm14 (SXP-1) [16], B.malayi Bm33 (Bm-AP-1) [17], andW. bancroftiWb123
[18] antigens were used. Wb123 is reported to be largely species specific [18, 19], while the
Bm14 and Bm33 antigens cross react with sera fromW. bancrofti infected patients as well as
with sera from some patients infected with other filarial worm species [17, 20].
Recombinant Bm14 [21], SAG2A [22], and NIE [23] proteins tagged with Schistosoma japo-
nicum glutathione-S-transferase (GST) and control GST with no fusion partner [24] were
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expressed and purified as described elsewhere. Bm33 [25] and T24H [26] were expressed with
GST fused to the amino terminus and with six histidines (His6) on the carboxy terminus and
purified as previously described. Following purification, the His6 tag was removed from T24H
by Factor Xa cleavage [26]. Recombinant PfMSP-119-GST (3D7 parasite strain) fusion protein
and PfMSP-142 proteins (3D7 and FVO parasite strains) lacking fusion tags were provided by
C. Kauth and H. Bujard (Heidelberg University, Heidelberg, Germany) [27]. Wb123-GST
fusion protein was provided by Dr. T. Nutman (NIH, Bethesda, MD).
The P. vivax PvMSP119-GST was cloned, expressed, and purified for the MBA. The coding
sequence (including the carboxy-terminal, hydrophobic anchor sequence) was amplified from
Belem strain DNA (provided by J. Barnwell, CDC, Atlanta, GA) using the following forward
and reverse deoxyoligonucleotide PCR primers: 5’-CGC GGA TCC ACT ATG AGC TCC
GAG CAC ACA TG-3’ and 5’-GCG GAA TTC TTA AAG CTC CAT GCA CAG GAG-3’,
respectively. BamHI and EcoRI restriction endonuclease sites used for directional cloning into
pGEX 4T-2 plasmid (GE Healthcare, USA) are underlined in the primer sequences. Polymer-
ase chain reaction amplification conditions and protocols for cloning into Escherichia coli
BL21 cells (Stratagene, USA) have previously been described [28]. The sequence of the result-
ing PvMSP119 clone was confirmed to match that found in GenBank (accession number
AF435594.1) [29]. Recombinant PvMSP119-GST fusion protein was expressed and purified on
a glutathione Sepharose 4B affinity column as directed by the manufacturer (GE Healthcare).
Glutathione-eluted proteins were dialyzed overnight against 300 volumes of 25 mM Tris buffer
at pH 7.5 using Spectra-Por3 dialysis membrane (3,500-Da cutoff, Spectrum Laboratories,
Rancho Dominguez, CA). Proteins were bound to a Mono Q HR5/5 strong anion exchange
column (GE Healthcare) and eluted with a 20 min linear gradient from 0 to 0.25 M NaCl in 25
mM Tris buffer at pH 7.5. Protein fractions collected between 0.15 and 0.21 M NaCl were
mostly free of contaminants by SDS polyacrylamide gel analysis and were combined. The final
Table 1. Coupling conditions and cutoff values for antigens used in parasitic disease MBA.
Infection (strain) Antigen Taga Protein (μg)b pHc Cutoff (MFI-bg)
Lymphatic ﬁlariasis Bm14 GST 120 7.2 65
Lymphatic ﬁlariasis Wb123 GST 120 7.2 115
Lymphatic ﬁlariasis Bm33 GST/His 20 6.0d 966
Strongyloidiasis NIE GST 20 7.2d 792
Toxoplasmosis SAG2A GST 20e 5.0 159
Cysticercosis T24H GST 120 5.0 486
Malaria (3D7)f PfMSP119 GST 30 5.0 343
Malaria (3D7)f PfMSP142 None 15 5.0 295
Malaria (FVO)f PfMSP142 None 15 5.0 141
Malaria (Belem)g PvMSP119 GST 20 5.0 196
Negative control Noneh GST 15 5.0 None
aGST, S. japonicum glutathione-S-transferase; His, histidine6.
bProtein amount used in a 0.5 ml coupling reaction with 12.5 x 106 SeroMap beads.
cpH 5.0 and 6.0 couplings conducted in MES/ NaCl buffer. pH 7.2 couplings conducted in Na2HPO4/ NaCl buffer. See text for concentrations.
dCoupling buffer included 2 M urea.
eNote that later studies decreased SAG2A to 12.5 μg/ml of beads [22].
fP. falciparum.
gP. vivax.
hRecombinant GST in the absence of additional protein sequence was coupled to beads as a negative control.
doi:10.1371/journal.pntd.0004699.t001
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protein product was dialyzed against 300 volumes of PBS and then concentrated to approxi-
mately 1 mg/ml using a Centricon-10 centrifugal filter device (Millipore Corporation, Bedford,
MA). The yield from 2 L of E. coli cells was approximately 1.5 mg of purified PvMSP119-GST
protein.
Multiplex bead antibody assays for parasitic diseases
Bm14-GST and Wb123-GST antigens (120 μg for 12.5 x 106 beads in 0.5 ml) were covalently
coupled to SeroMap microsphere beads (Luminex Corp., Austin, TX) using conditions previ-
ously described in buffer containing 10 mMNa2HPO4 and 0.85% NaCl at pH 7.2 (PBS) [25].
For the other antigens, coupling buffers for conjugation were empirically chosen to minimize
protein usage and maximize the signal/ noise ratio (shown in Table 1). A small scale coupling
reaction (50 μl containing 6.25 x 105 beads) conducted at a protein concentration of 120 μg/ ml
in PBS at pH 7.2 was compared to small scale coupling reactions performed in phosphate
buffer at pH 7.2 or in buffers containing 2-(N-morpholino)-ethanesulfonic acid (MES) at pH
5.0 or 6.0. Protein concentrations were varied from 120 μg/ ml to as low as 10 μg/ ml. Each
small scale coupling was conducted using a different bead classification number so that the
beads could be combined in a single assay well for analysis. The efficiencies of the couplings
were compared by MBA (conditions described below) using a serial dilution of a strong posi-
tive human serum, a panel of positive and negative human sera, or a 10-fold serial dilution of a
goat anti-GST polyclonal antibody (GE Healthcare) with a biotinylated rabbit anti-goat IgG
secondary antibody (1:500 dilution; Invitrogen, Carlsbad, CA). Antigens coupled in 0.5 ml of
25 mMMES at pH 5.0 with 0.85% NaCl used the following amounts of protein for 12.5 x 106
beads: SAG2A-GST, 20 μg; T24H-GST, 120 μg; PfMSP-119-GST, 30 μg; PfMSP-142 proteins,
15 μg; PvMSP119-GST, 20 μg; GST control protein, 15 μg. The two antigens purified in the
presence of 2 M urea required 2 M urea in the coupling buffer to minimize the MBA response
to negative human sera. Bm33-GST-His6 (20 μg for 12.5 x 10
6 beads in 0.5 ml) was coupled in
buffer containing 25 mMMES, 2 M urea, and 200 mMNaCl at pH 6.0. NIE-GST (20 μg for
12.5 x 106 beads in 0.5 ml) was coupled in buffer containing 50 mMNa2HPO4, 2 M urea, and
200 mMNaCl at pH 7.2.
Test sera were diluted 1:400 in PBS buffer (pH 7.2) containing 0.3% Tween-20, 0.02%
sodium azide, 0.5% BSA, 0.5% casein, 0.5% polyvinyl alcohol (PVA), 0.8% polyvinylpyrroli-
done (PVP), and 3 μg/ml E. coli extract, and duplicate samples were assayed for total IgG anti-
bodies as previously described [21, 25, 30]. Casein was found to provide additional background
noise reductions for the NIE and Bm33 assays compared to PVA and PVP alone. Assay perfor-
mance was monitored by the inclusion on each plate of two positive control serum dilutions,
two negative control serum dilutions, and a buffer-only blank. The average of the median fluo-
rescent intensity values from the duplicate wellsminus the background fluorescence from the
buffer-only blank was reported as the “median fluorescence intensityminus background”
(MFI-bg). Samples having a coefficient of variation of>15% for2 positive responses between
the duplicate wells were repeated.
Because several of the parasitic diseases represented in our MBA panel are not endemic in
the United States (U.S.), we were able to use serum samples from 86 healthy, adult US citizens
with no history of foreign travel to define positive IgG response cutoffs [25]. Cutoffs for Bm14
(65 MFI-bg), Wb123 (115 MFI-bg), Bm33 (966 MFI-bg), NIE (792 MFI-bg), and T24H (486
MFI-bg) were based on the mean plus three standard deviations of the respective antibody
response values (Table 1). Cutoffs for PfMSP119 (343 MFI-bg) and PvMSP119 (196 MFI-bg)
were calculated using the mean plus three standard deviations of log transformed antibody
response values (Table 1) [31]. Panels of parasitologically confirmed, anonymous sera were
Parasitic Disease Seroprevalence Among CambodianWomen
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available for MBA sensitivity determinations for malaria antigens (slide microscopy positive
patients, P. falciparum n = 33 and P. vivax n = 35), S. stercoralis NIE antigen (stool positive
patients, n = 44), and cysticercosis T24H antigen (patients with multiple cysts confirmed by
CT or MRI scan, n = 52).
The significant prevalence of toxoplasmosis in the U.S. population [32] required the use of
an alternate means of cutoff determination for the SAG2A antigen. A panel of positive and
negative sera (n = 45) identified using the “gold standard” Sabin-Feldman dye binding assay
was tested by MBA, and the average of the highest negative value (22 MFI-bg) and the lowest
positive value (295 MFI-bg) was chosen as the positive cutoff (159 MFI-bg) (Table 1) [22, 33].
Statistical analysis
An alpha of 0.05 was set for tests of statistical significance. Statistical analyses were conducted
using SAS v9.3 (Cary, NC, USA) and STATA v 13.1 (College Station, TX, USA). Briefly, sam-
pling weights were calculated to take each stage of selection into account, including the proba-
bility of selecting the original EAs in the 2010 DHS. A non-response adjustment by strata was
included using the weighting class approach. Final weights were scaled to conform to the
regional distribution of the population in the 2008 census [34]. Estimates of seroprevalence
and coverage with 95% (logit) confidence intervals (CI) were calculated accounting for survey
design (STATA v13.1). Second-order Rao-Scott Chi-square tests were used to assess differences
in seroprevalence across age groups, regions, and rural/urban residence.
Results
The cutoff values assigned to the various parasite MBAs in Table 1 performed well when the
assays were used to test serum panels from parasite infection-confirmed patients. All three P.
falciparumMBAs detected IgG antibodies in 75.8% of the slide positive serum panel, and each
positive serum reacted with all three antigens. Unfortunately, demographic information and
details on the timing of sample collection relative to malaria infection were not available for
this anonymous sample set. Specificities calculated from the U.S. citizen negative control panel
ranged from 100% (PfMSP119) to 96.5% (PfMSP142). The PvMSP119, S. stercoralis NIE, and
cysticercosis T24HMBAs had sensitivities of 85.7%, 84.1%, and 98.1%, respectively. Specifici-
ties calculated from the U.S. citizen negative control panel were 98.8% for each assay. As previ-
ously reported, the T. gondii SAG2AMBA was 100% sensitive and specific compared to a
“gold standard” assay defined panel [22]. Sensitivities were not determined for the LF antigen
MBAs; they were>97.7% specific with our U.S. negative samples.
Although the Cambodia population survey was not powered to detect differences in anti-
body prevalence across EAs, a plot of median values of the data sorted first by EA and then by
region revealed distinct high and low median prevalence values for some of the parasite-spe-
cific antibody responses. A single EA in the Steung Treng province of the North geographic
region of the country was found to have coincident peaks of high antibody responses to all
three LF antigens (Fig 1A). Multiple North region EAs located in the provinces of Kratie, Preah
Vihear, Ratanakiti, and Steung Treng had coincident peaks of antibody reactivity to the P. fal-
ciparum and the P. vivaxMSP119 antigens (Fig 1B). A weak median response peak in the West
region province of Pursat was also detected. Median antibody response plots for the FVO and
3D7 PfMSP142 antigens largely mirrored those observed with the PfMSP119 antigen (S1 Fig).
Because the MSP142 antigens included the MSP119 sequence, these responses were not further
analyzed. Multiple peaks of antibody to S. stercoralis NIE were observed throughout the coun-
try, and only the largely urban Phnom Penh region had EAs with relatively low median
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Fig 1. Median plots for LF responses (A) andmalaria responses (B) in Cambodian women 15–39 years of age. A, Multiplex bead assay results for
Bm14 (black), Bm33 (red), andWb123 (gray) were grouped first by Enumeration Area (EA) and then by geographic region as follows: North (Banteay Mean
Chey, Kampong Thom, Kratie, Mondolkiri, Otdar Mean Chey, Preah Vihear, Ratanakiri, Siem Reap, and Steung Treng provinces), West (Battambang,
Kampong Chhang, Kampong Speu, Koh Kong, Pailin, Preah Sihanouk, and Pursat provinces), Southwest (Kampot, Kandal, Kep, and Takeo provinces),
Southeast (Kampong Cham, Prey Veng, and Svay Rieng provinces), and Phnom Penh [6]. A median MFI-bg result was calculated for each EA and is plotted
Parasitic Disease Seroprevalence Among CambodianWomen
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responses (Fig 2A). For toxoplasmosis and cysticercosis there was no discernible geographic
clustering of the antibody responses detected (Fig 2B).
Weighted national estimates for toxoplasmosis and cysticercosis were 5.8% (CI, 4.7–7.0)
and 2.6% (CI, 1.8–3.7), respectively, with no statistically significant urban/ rural, regional, or
age-related differences noted (S1 Table). Weighted national estimates of seroprevalence for P.
falciparum (4.6%; CI, 3.1–6.8) and P. vivax (4.6%; CI, 3.3–6.4) malaria are shown in Table 2.
Antibody prevalence was significantly higher in rural areas than urban areas for P. falciparum
(P = 0.005) and P. vivax (P = 0.014). Regional differences in seroprevalence were statistically
significant for P. falciparum and P. vivax (Table 2), with the North region having higher sero-
prevalence than the other regions combined for P. falciparum (13.7% vs. 1.9%; P< 0.001) and
P. vivax (9.2% vs. 3.2%; P = 0.003). No age related differences were noted for either malaria spe-
cies. For the LF estimate (Table 3) we required that antibodies to two or more of the LF anti-
gens be present for a sample to be considered positive. The national LF estimate was low at
only 2.4% (CI, 1.6–3.6), but statistically significant rural/ urban (P = 0.039) and regional
(P< 0.001) differences were observed with the latter driven by a higher prevalence of 5.6% (CI,
3.0–10.2) in the North region. In contrast to the low seroprevalence estimates for the parasitic
diseases mentioned above, just under half of women of child-bearing age in our countrywide
sample of Cambodia were positive for antibodies to S. stercoralis (45.9%, CI, 41.7–50.1)
(Table 3). Differences between regions (P< 0.001) and between urban and rural populations
were highly significant (P = 0.003), but no age differences were detected (P = 0.195).
Discussion
In a previous report, we used the multiplex bead assay to determine anti-tetanus toxoid anti-
body levels in Cambodian women of child-bearing age and demonstrated that the estimates of
population immunity derived from the multiplex testing were very similar to those derived
from the “gold standard” assay methodologies [7]. Here we demonstrate that multiplexed anti-
body assays, when integrated into the robust, population-based Cambodian serologic survey
framework, can be used to provide nationally-representative estimates of the presence and dis-
tribution of a number of parasitic diseases of public health importance. Although others have
used multiplex assays to measure multiple anti-parasite antibody responses [35], this report is,
to our knowledge, the first to generate national parasitic disease estimates from multiplexed
serologic antibody assays.
Cambodia recently completed five years of mass drug administration (MDA) to eliminate
lymphatic filariasis in a small number of northern and northeastern provinces where the pres-
ence of infection had been documented by antigen surveys (http://www.who.int/neglected_
diseases/preventive_chemotherapy/lf/en/) [36]. Our results demonstrate the presence of signif-
icant residual antibody reactivity in the geographic North area where the MDA occurred and,
perhaps of greater importance, its relative absence in areas where MDA was not carried out.
These results are an important confirmation of the baseline mapping data that was used as the
basis for determining where to implement MDA. The presence of residual antibody following
MDA, as high as 60% in one EA, is not surprising as antifilarial antibody responses in adults
are known to be long-lived [37, 38]. Although sampling of children may be of greater value in
the post-MDA setting as a measure of incident seroconversions, these results suggest the
potential use of LF antibody testing as a tool for LF surveillance. Additional information on the
versus region. A single coincident peak of LF reactivity was noted in a single EA in the North region. B, Median multiplex results for P. vivax (black) and P.
falciparum (red) MSP119 antigens were calculated as described in A. Note that the results for P. vivaxMSP119 are plotted on the left hand y-axis while those
for P. falciparumMSP119 are plotted on the right hand y-axis.
doi:10.1371/journal.pntd.0004699.g001
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Fig 2. Median plots for parasitic disease responses in Cambodian women 15–39 years of age.
Antibody results for a strongyloidiasis antigen (A), and toxoplasmosis (black) and cysticercosis (gray)
antigens (B) were grouped as described in Fig 1. A median MFI-bg result was calculated for each EA and is
plotted versus region.
doi:10.1371/journal.pntd.0004699.g002
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Table 2.
P. falciparum MSP119 MBAa P. vivax MSP119 MBAa
Characteristic Total Positive Percent LCL UCL P value Positive Percent LCL UCL P value
Overall 2150 174 4.6 3.1 6.8 114 4.6 3.3 6.4
Residence type
Urban 655 14 2.0 1.1 3.6 0.005 16 2.1 1.1 4.2 0.014
Rural 1495 160 5.3 3.4 8.2 98 5.3 3.7 7.6
Region
North 394 131 13.7 6.8 25.7 <0.001 56 9.2 4.7 17.5 0.003
West 445 24 3.3 1.0 10.2 22 4.1 2.2 7.6
Southwest 423 7 1.1 0.5 2.8 17 4.2 2.1 8.1
Southeast 419 5 1.4 0.7 3.1 9 2.1 1.1 4.2
Phnom Penh 469 7 1.2 0.5 2.7 10 1.9 0.8 4.7
Age group (yr)
15–19 435 34 3.9 1.9 7.9 0.245 20 3.0 1.8 5.1 0.249
20–24 468 34 4.0 2.5 6.3 22 3.6 2.0 6.2
25–29 483 32 4.3 2.5 7.2 26 3.9 2.4 6.0
30–34 449 35 4.2 2.4 7.2 22 5.9 2.2 14.6
35–39 315 39 6.9 4.1 11.4 24 7.0 4.9 10.0
aEstimates adjusted to account for sampling weights and survey design.
Abbreviations: LCL, Lower conﬁdence limit; UCL, Upper conﬁdence limit.
doi:10.1371/journal.pntd.0004699.t002
Table 3.
Strongyloides stercoralis NIE MBAa Lymphatic ﬁlariasis MBA (any two antigens)a
Characteristic Total Positive Percent LCL UCL P value Positive Percent LCL UCL P value
Overall 2150 935 45.9 41.7 50.1 52 2.4 1.6 3.6
Residence type
Urban 655 197 32.4 23.4 43.0 0.003 9 1.0 0.4 2.7 0.039
Rural 1495 738 49.8 44.9 54.6 43 2.8 1.9 4.3
Region
North 394 202 58.3 47.1 68.6 <0.001 26 5.6 3.0 10.2 <0.001
West 445 234 52.7 42.7 62.4 7 1.4 0.6 3.1
Southwest 423 192 42.9 35.5 50.7 7 1.8 0.9 3.5
Southeast 419 167 39.0 30.6 48.1 5 1.4 0.6 3.6
Phnom Penh 469 140 26.1 19.2 34.3 7 1.2 0.5 3.2
Age group (yr)
15–19 435 160 39.9 33.7 46.5 0.195 9 1.5 0.8 3.0 0.323
20–24 468 196 45.4 37.9 53.0 11 1.7 0.5 5.5
25–29 483 211 43.8 37.0 50.8 13 2.5 1.3 4.7
30–34 449 206 51.0 44.7 57.2 11 2.4 1.0 5.9
35–39 315 162 49.8 39.8 59.9 8 4.3 2.3 7.7
aEstimates adjusted to account for sampling weights and survey design.
Abbreviations: LCL, Lower conﬁdence limit; UCL, Upper conﬁdence limit.
doi:10.1371/journal.pntd.0004699.t003
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longevity of responses in adults is needed to guide recommendations on the use of antibody
surveys for post-MDA surveillance.
The two other vector borne parasitic infections in our panel, P. falciparum and P. vivax
malaria, were also focally distributed with seroprevalence for PfMSP119 antibody approaching
100% in some EAs (S1 Data). Both of our national malaria seroprevalence estimates (4.6% for
P. falciparum and 4.6% for P. vivax) were considerably higher than the 0.9% blood film parasite
prevalence estimate for all species of malaria generated by the Cambodia Ministry of Health in
2010 [39]. From samples collected in Cambodia in 2005, Cook et al. [40] reported a P. falcipa-
rum peak seasonal seroprevalence of 49.2% compared to a parasite prevalence by slide micros-
copy of only 3.4% (November, western provinces) and a P. vivax seroprevalence of 20.2%
compared to a 10.7% parasite prevalence (August, eastern province). The discrepancies
between the parasite prevalence by blood film microscopy and the parasite-specific IgG anti-
body prevalence may reflect low malaria parasite loads that remain below the limit of micro-
scopic detection [41, 42], or, as in the case of LF described above, may result from a long IgG
titer half-life following successful treatment [43]. Although the public health value of malaria
serosurveys in adults may be limited to confirming the known distributions of those infections,
serosurveys in young children, as with LF, may provide useful surveillance data for mapping
transmission foci in the context of malaria elimination efforts and may offer an opportunity to
monitor the impact of interventions by documenting reductions in seroprevalence over time
[44, 45].
From our MBA results, prevalence of IgG antibody to toxoplasmosis (3.5–7.3%) and to cys-
ticercosis (1.3–3.3%) was relatively low across all geographic regions. Few surveys have been
conducted for either of these infections in Cambodia [46, 47], but our values are consistent
with the limited information available. Seroprevalence of IgG antibodies to T. gondii among
women<40 years of age in Phnom Penh was 8.4% in one small study [48]. A low seropreva-
lence suggests that the majority of women of child-bearing age in Cambodia are at risk of pri-
mary T. gondii infection and could, if infected during pregnancy, transmit toxoplasmosis to
their babies in utero with serious health consequences [49, 50].
Recent stool-based detection surveys by Khieu et al. have found low levels of Taenia solium
tapeworm infection in Cambodia: 0.4% in Preah Vihear province, 0.4% in children in Kandal
province, and only 0.1% in Takeo province [51–53]. National estimates of infection prevalence
among school children in neighboring Lao PDR were similarly low: 0–1.8% at the provincial
level by stool assay [54]. The relatively low prevalence of intestinal tapeworm infection and the
low prevalence of antibodies to the cysticercosis antigen in our study of adult women suggest
that the risk of eliciting neurocysticercosis through mass drug administration with either prazi-
quantel (for schistosomiasis) or albendazole (for soil transmitted helminthiasis) is likely to be
low in this setting- a useful observation for the Ministry of Health in planning NTD
interventions.
A somewhat surprising result from our study was the high seroprevalence of S. stercoralis
infection throughout Cambodia. S. stercoralis is thought to establish life-long infection because
of its propensity for autoinfection [55], and, in immunocompromised patients, a hyperinfec-
tion syndrome with a high case mortality may result [56]. The sensitivity of the S. stercoralis
assay determined using samples from stool-confirmed cases suggested that the assay that was
only 84% sensitive. Thus, it is possible that our results are, in fact, an underestimate of true
infection prevalence. Previous surveys have documented a high prevalence (21–44.7%) of
strongyloidiasis using stool assays [51–53]; the present results establish that this problem is
national in scope. Strongyloidiasis does respond to ivermectin therapy and MDA with ivermec-
tin is a cornerstone of efforts to eliminate onchocerciasis and lymphatic filariasis in sub-Saha-
ran Africa; however, there is currently no WHO guidance on either the dosage or treatment
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schedule that would be required to carry out MDA with ivermectin to control Strongyloides in
other settings. In addition, donation programs for this drug are currently restricted to the two
filarial infections.
A key factor in the successful completion of this integrated survey was the forward-looking
decision of survey planners to include specific language in the consent form that permitted test-
ing for multiple infections. Such permissive language is not currently a standard feature of
most surveys, and obtaining ethical approvals for retrospective testing of stored specimens can
be problematic. When serum or blood spot collection is included in population-based surveys,
survey planners should include permissive language in consent forms to allow a broader
approach to integrated serosurveys.
Although multiplexing technology has tremendous potential for integrated serosurveys,
some limitations in our study must be acknowledged. First, defining robust cutoffs to deter-
mine seropositivity can be challenging for some antigens, especially when banks of true nega-
tive sera and of positive sera from parasitologically confirmed cases are not readily available.
For most antigens in our MBA panel, we used a non-endemic negative control sample set in
order to establish a cutoff. This approach may not have been ideal, and additional efforts will
be needed to standardize procedures and cutoff values across multiple labs.
Second, while we included in our MBA panel only highly purified recombinant antigens
that had been successfully used in other serologic assay formats, sensitivity and specificity are a
potential concern, especially when only one parasite antigen is used in the multiplex. Based on
the earlier work of Bousema et al. [57], the antibody responses to the two Plasmodium spp.
MSP119 proteins are not expected to be cross-reactive, but we are currently examining this in
more detail. We have, however, observed that the distribution of responses to helminth anti-
gens, in particular, may be influenced by the background exposures to other helminth parasites
and cross-reactivities may result in false-positives in the Bm14 response [20]. Such specificity
concerns can be mitigated by including multiple parasite antigens in the MBA, as we did here
with three unrelated LF antigens.
Third, the current survey only included women of child-bearing age and was specifically
designed to provide seroprevalence estimates for tetanus, and rubella at the regional level [6,
7]. No epidemiologic information relative to parasitic diseases (i.e., bed net use) was collected.
While the survey was well-suited for the concurrent analysis of congenital toxoplasmosis risk,
the possibility of gender- or age-specific differences in either the prevalence or distribution of
some of the other infections of interest must be acknowledged. For example, several studies
have shown that men have a higher prevalence of strongyloidiasis than women [51, 52], and
gender differences in malaria prevalence are often noted in Cambodia because men are more
frequently exposed to vector mosquitoes while working in sylvan environments [58, 59]. Simi-
larly, the study design did not take into account potential seasonal differences (important for
malaria) as samples were collected only in November and December of 2012 at the beginning
of the dry season [40].
Fourth, because of their small populations and remoteness, the provinces with the highest
expected levels of malaria and LF were represented in the national survey by few EAs. This
reflects the fact that the study was powered to compare regional prevalence estimates rather
than estimates at the province, district, or EA level. Nevertheless, hot spots of parasite-specific
antibody responses were observed in the nationwide survey, and, once identified, these areas
could certainly be targeted for more focal screening in future surveys.
Despite these limitations, the use of the antibody multiplex assay in the context of a nation-
ally representative survey provides a proof of principle of the potential utility of integrated pro-
grammatic monitoring and evaluation for many diseases. The multiplex assay is a flexible
platform that can integrate monitoring and evaluation opportunities for various conditions
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and that can easily be adapted to meet country needs. It is our hope that this work will help fur-
ther the idea of combining efforts for integrated monitoring and surveillance activities among
global public health organizations.
Supporting Information
S1 Fig. Median plots for P. falciparumMSP142 3D7 and FVO antibody responses.
(TIF)
S1 Table. Weighted national estimates for toxoplasmosis and cysticercosis.
(DOCX)
S1 Data. Supporting information data file.
(XLS)
S1 Checklist. STROBE Checklist.
(DOC)
Acknowledgments
The authors thank C. Kauth and H. Bujard (Heidelberg University, Heidelberg, Germany) for
PfMSP119 protein and T. Nutman (NIH, Bethesda, MD) for Wb123 protein. We thank J. Barn-
well (CDC, Atlanta, GA) for Belem strain P. vivax DNA and Ira Goldman (CDC, Atlanta, GA)
for DNA sequencing assistance. The authors express their gratitude to the study participants
and to the field teams in Cambodia.
Use of trade names is for identification only and does not imply endorsement by the Public
Health Service or by the U.S. Department of Health and Human Services. The findings and
conclusions in this report are those of the authors and do not necessarily represent the official
position of the Centers for Disease Control and Prevention.
Author Contributions
Conceived and designed the experiments: JWP MHJ DMM BM SB KW SCS NWL VU CJG
RH SM PJL. Performed the experiments: JWP MHJ DMM BM SB KW SCS NWL VU CJG RH
SM PJL. Analyzed the data: JWPMHJ DMMKW PJL. Contributed reagents/materials/analysis
tools: JWP MHJ DMMKWNWL VU. Wrote the paper: JWPMHJ DMM BM SB KW SCS
NWL VU CJG RH SM PJL.
References
1. Savioli L, Daumerie D. Accelerating work to overcome the global impact of neglected tropical diseases:
A roadmap for implementation. Geneva, Switzerland: World Health Organization; 2012.
2. Schar F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: Global Distri-
bution and Risk Factors. PLoS neglected tropical diseases. 2013; 7(7):e2288. doi: 10.1371/journal.
pntd.0002288 PMID: 23875033; PubMed Central PMCID: PMCPMC3708837.
3. Krolewiecki AJ, Lammie P, Jacobson J, Gabrielli AF, Levecke B, Socias E, et al. A public health
response against Strongyloides stercoralis: time to look at soil-transmitted helminthiasis in full. PLoS
neglected tropical diseases. 2013; 7(5):e2165. doi: 10.1371/journal.pntd.0002165 PMID: 23675541;
PubMed Central PMCID: PMCPMC3649958.
4. Fabic MS, Choi Y, Bird S. A systematic review of Demographic and Health Surveys: data availability
and utilization for research. Bulletin of theWorld Health Organization. 2012; 90:604–12. doi: 10.2471/
BLT.11.095513 PMID: 22893744
5. Lammie PJ, Moss DM, Brook Goodhew E, Hamlin K, Krolewiecki A, West SK, et al. Development of a
new platform for neglected tropical disease surveillance. International journal for parasitology. 2012; 42
(9):797–800. doi: 10.1016/j.ijpara.2012.07.002 PMID: 22846784.
Parasitic Disease Seroprevalence Among CambodianWomen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004699 May 3, 2016 13 / 16
6. Mao B, Chheng K, Wannemuehler K, Vynnycky E, Buth S, Soeung SC, et al. Immunity to polio, mea-
sles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence,
Cambodia, 2012. Epidemiology and infection. 2014:1–10. doi: 10.1017/S0950268814002817 PMID:
25373419.
7. Scobie HM, Mao B, Buth S, Wannemuehler KA, Sorensen C, Kannarath C, et al. Tetanus immunity
among women aged 15–39 years in Cambodia: A national population-based serosurvey, 2012. Clinical
and vaccine immunology: CVI. 2016. doi: 10.1128/CVI.00052-16 PMID: 27053629.
8. Ravi V, Ramachandran S, Thompson RW, Andersen JF, Neva FA. Characterization of a recombinant
immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Molecular and bio-
chemical parasitology. 2002; 125(1–2):73–81. PMID: 12467975.
9. Prince JB, Auer KL, Huskinson J, Parmley SF, Araujo FG, Remington JS. Cloning, expression, and
cDNA sequence of surface antigen P22 from Toxoplasma gondii. Molecular and biochemical parasitol-
ogy. 1990; 43(1):97–106. PMID: 2290448.
10. Parmley SF, Sgarlato GD, Mark J, Prince JB, Remington JS. Expression, characterization, and sero-
logic reactivity of recombinant surface antigen P22 of Toxoplasma gondii. Journal of clinical microbiol-
ogy. 1992; 30(5):1127–33. PMID: 1583109; PubMed Central PMCID: PMC265236.
11. Hancock K, Pattabhi S, Whitfield FW, Yushak ML, LaneWS, Garcia HH, et al. Characterization and
cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Molecular and biochemical parasi-
tology. 2006; 147(1):109–17. doi: 10.1016/j.molbiopara.2006.02.004 PMID: 16540186.
12. BlackmanMJ, Ling IT, Nicholls SC, Holder AA. Proteolytic processing of the Plasmodium falciparum
merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth
factor-like domains. Molecular and biochemical parasitology. 1991; 49(1):29–33. PMID: 1775158.
13. Egan AF, Chappel JA, Burghaus PA, Morris JS, McBride JS, Holder AA, et al. Serum antibodies from
malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor
motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmo-
dium falciparum. Infection and immunity. 1995; 63(2):456–66. PMID: 7822010; PubMed Central
PMCID: PMC173017.
14. del Portillo HA, Longacre S, Khouri E, David PH. Primary structure of the merozoite surface antigen 1 of
Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proceedings
of the National Academy of Sciences of the United States of America. 1991; 88(9):4030–4. PMID:
2023952; PubMed Central PMCID: PMC51587.
15. Longacre S, Mendis KN, David PH. Plasmodium vivax merozoite surface protein 1 C-terminal recombi-
nant proteins in baculovirus. Molecular and biochemical parasitology. 1994; 64(2):191–205. PMID:
7935598.
16. Chandrashekar R, Curtis KC, Ramzy RM, Liftis F, Li BW, Weil GJ. Molecular cloning of Brugia malayi
antigens for diagnosis of lymphatic filariasis. Molecular and biochemical parasitology. 1994; 64(2):261–
71. PMID: 7935604.
17. Dissanayake S, Xu M, Nkenfou C, PiessensWF. Molecular cloning and serological characterization of
a Brugia malayi pepsin inhibitor homolog. Molecular and biochemical parasitology. 1993; 62(1):143–6.
PMID: 8114819.
18. Kubofcik J, Fink DL, Nutman TB. Identification of Wb123 as an early and specific marker of Wuchereria
bancrofti infection. PLoS neglected tropical diseases. 2012; 6(12):e1930. doi: 10.1371/journal.pntd.
0001930 PMID: 23236529; PubMed Central PMCID: PMC3516582.
19. Steel C, Golden A, Kubofcik J, LaRue N, de Los Santos T, Domingo GJ, et al. Rapid Wuchereria ban-
crofti-specific antigenWb123-based IgG4 immunoassays as tools for surveillance following mass drug
administration programs on lymphatic filariasis. Clinical and vaccine immunology: CVI. 2013; 20
(8):1155–61. doi: 10.1128/CVI.00252-13 PMID: 23740923; PubMed Central PMCID:
PMCPMC3754496.
20. Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, et al. Recombinant antigen-based anti-
body assays for the diagnosis and surveillance of lymphatic filariasis—a multicenter trial. Filaria journal.
2004; 3(1):9. doi: 10.1186/1475-2883-3-9 PMID: 15347425; PubMed Central PMCID: PMC519021.
21. Hamlin KL, Moss DM, Priest JW, Roberts J, Kubofcik J, Gass K, et al. Longitudinal monitoring of the
development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area
of Haiti. PLoS neglected tropical diseases. 2012; 6(12):e1941. doi: 10.1371/journal.pntd.0001941
PMID: 23236534; PubMed Central PMCID: PMC3516578.
22. Priest JW, Moss DM, Arnold BF, Hamlin K, Jones CC, Lammie PJ. Seroepidemiology of Toxoplasma in a
coastal region of Haiti: multiplex bead assay detection of immunoglobulin G antibodies that recognize the
SAG2A antigen. Epidemiology and infection. 2015; 143(3):618–30. doi: 10.1017/S0950268814001216
PMID: 25600668.
Parasitic Disease Seroprevalence Among CambodianWomen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004699 May 3, 2016 14 / 16
23. Rascoe LN, Price C, Shin SH, McAuliffe I, Priest JW, Handali S. Development of Ss-NIE-1 recombinant
antigen based assays for immunodiagnosis of strongyloidiasis. PLoS neglected tropical diseases.
2015; 9(4):e0003694. doi: 10.1371/journal.pntd.0003694 PMID: 25860665; PubMed Central PMCID:
PMC4393093.
24. Moss DM, Montgomery JM, Newland SV, Priest JW, Lammie PJ. Detection of cryptosporidium antibod-
ies in sera and oral fluids using multiplex bead assay. The Journal of parasitology. 2004; 90(2):397–
404. doi: 10.1645/GE-3267 PMID: 15165066.
25. Moss DM, Priest JW, Boyd A, Weinkopff T, Kucerova Z, Beach MJ, et al. Multiplex bead assay for
serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.
The American journal of tropical medicine and hygiene. 2011; 85(2):229–37. doi: 10.4269/ajtmh.2011.
11-0029 PMID: 21813840; PubMed Central PMCID: PMC3144818.
26. Corstjens PL, de Dood CJ, Priest JW, Tanke HJ, Handali S, Cysticercosis Working Group in P. Feasibil-
ity of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a light-
weight strip analyzer. PLoS neglected tropical diseases. 2014; 8(7):e2944. doi: 10.1371/journal.pntd.
0002944 PMID: 24992686; PubMed Central PMCID: PMC4080996.
27. Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW,Woehlbier U, et al. Antibody responses to the
merozoite surface protein-1 complex in cerebral malaria patients in India. Malaria journal. 2008; 7:121.
doi: 10.1186/1475-2875-7-121 PMID: 18601721; PubMed Central PMCID: PMC2491629.
28. Priest JW, Moss DM, Visvesvara GS, Jones CC, Li A, Isaac-Renton JL. Multiplex assay detection of
immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.
Clinical and vaccine immunology: CVI. 2010; 17(11):1695–707. doi: 10.1128/CVI.00160-10 PMID:
20876825; PubMed Central PMCID: PMC2976096.
29. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, KhoW-G, Kaneko A, et al. Mosaic organiza-
tion and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface
protein-1 locus. Proceedings of the National Academy of Sciences. 2002; 99(25):16348–53. doi: 10.
1073/pnas.252348999
30. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. Jour-
nal of immunological methods. 2006; 309(1–2):200–4. doi: 10.1016/j.jim.2005.11.008 PMID: 16406059.
31. Arnold BF, Priest JW, Hamlin KL, Moss DM, Colford JM Jr., Lammie PJ. Serological measures of
malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PloS one. 2014;
9(4):e93684. doi: 10.1371/journal.pone.0093684 PMID: 24691467; PubMed Central PMCID:
PMC3972142.
32. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United
States, 1999 2004, decline from the prior decade. The American journal of tropical medicine and
hygiene. 2007; 77(3):405–10. PMID: 17827351.
33. Sabin AB, Feldman HA. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a
Protozoon Parasite (Toxoplasma). Science. 1948; 108(2815):660–3. doi: 10.1126/science.108.2815.
660 PMID: 17744024.
34. National Institute of Statistics, Ministry of Planning, Royal Government of Cambodia. General Popula-
tion Census of Cambodia 2008: final census results 2009 [August 11, 2014]. Available from: http://
www.nis.gov.kh/nis/census2008/Census.pdf.
35. Fujii Y, Kaneko S, Nzou SM, Mwau M, Njenga SM, Tanigawa C, et al. Serological surveillance develop-
ment for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite
mixture models. PLoS neglected tropical diseases. 2014; 8(7):e3040. doi: 10.1371/journal.pntd.
0003040 PMID: 25078404; PubMed Central PMCID: PMC4117437.
36. Leang R, Socheat D, Bin B, Bunkea T, Odermatt P. Assessment of disease and infection of lymphatic
filariasis in Northeastern Cambodia. Tropical medicine & international health: TM & IH. 2004; 9
(10):1115–20. doi: 10.1111/j.1365-3156.2004.01311.x PMID: 15482405.
37. Supali T, Djuardi Y, Bradley M, Noordin R, Ruckert P, Fischer PU. Impact of six rounds of mass drug
administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia. PLoS
neglected tropical diseases. 2013; 7(12):e2586. doi: 10.1371/journal.pntd.0002586 PMID: 24349595;
PubMed Central PMCID: PMC3861187.
38. Wamae CN, Roberts JM, Eberhard ML, Lammie PJ. Kinetics of circulating human IgG4 after diethylcar-
bamazine and ivermectin treatment of bancroftian filariasis. The Journal of infectious diseases. 1992;
165(6):1158–60. PMID: 1583340.
39. National Centre for Parasitology EaMC, Royal Government of Cambodia. Cambodia malaria survey
20102010; (March 31):[1–178 pp.]. Available from: http://malariasurveys.org/documents/CMS%
202010%20GF%20Report%20(FINAL).pdf.
40. Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evalua-
tion of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy
Parasitic Disease Seroprevalence Among CambodianWomen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004699 May 3, 2016 15 / 16
season in Cambodia. Malaria journal. 2012; 11:86. doi: 10.1186/1475-2875-11-86 PMID: 22443375;
PubMed Central PMCID: PMC3364147.
41. Steenkeste N, Rogers WO, Okell L, Jeanne I, Incardona S, Duval L, et al. Sub-microscopic malaria
cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province,
Cambodia: implication for malaria elimination. Malaria journal. 2010; 9:108. doi: 10.1186/1475-2875-9-
108 PMID: 20409349; PubMed Central PMCID: PMC2868861.
42. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occur-
rence of submicroscopic malaria infections and their relevance for control. Nature communications.
2012; 3:1237. doi: 10.1038/ncomms2241 PMID: 23212366; PubMed Central PMCID: PMC3535331.
43. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, et al. Estimating medium-
and long-term trends in malaria transmission by using serological markers of malaria exposure. Pro-
ceedings of the National Academy of Sciences of the United States of America. 2005; 102(14):5108–13.
doi: 10.1073/pnas.0408725102 PMID: 15792998; PubMed Central PMCID: PMC555970.
44. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, et al. Effect of yearly mass
drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a com-
prehensive assessment. Lancet. 2006; 367(9515):992–9. doi: 10.1016/S0140-6736(06)68426-2 PMID:
16564361.
45. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, et al. Using serological measures to moni-
tor changes in malaria transmission in Vanuatu. Malaria journal. 2010; 9:169. doi: 10.1186/1475-2875-
9-169 PMID: 20553604; PubMed Central PMCID: PMC2904786.
46. Nissapatorn V. Toxoplasmosis: A silent threat in southeast Asia. Research Journal Parasitology. 2007;
2(1):1–12.
47. Willingham AL 3rd, Wu HW, Conlan J, Satrija F. Combating Taenia solium cysticercosis in Southeast
Asia an opportunity for improving human health and livestock production. Advances in parasitology.
2010; 72:235–66. doi: 10.1016/S0065-308X(10)72009-1 PMID: 20624534.
48. Richard-Lenoble D, Cheng HK, Sire JM, Duong TH, Cheng TV, Phanny I, et al. Toxoplasmose au Cam-
bodge: premiere evaluation serologique a Phnom Penh. Cahiers Sante. 1999; 9:377–82.
49. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii
seroprevalence and implications for pregnancy and congenital toxoplasmosis. International journal for
parasitology. 2009; 39(12):1385–94. doi: 10.1016/j.ijpara.2009.04.003 PMID: 19433092.
50. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review.
Bulletin of the World Health Organization. 2013; 91(7):501–8. doi: 10.2471/BLT.12.111732 PMID:
23825877; PubMed Central PMCID: PMC3699792.
51. Khieu V, Schar F, Forrer A, Hattendorf J, Marti H, Duong S, et al. High prevalence and spatial distribu-
tion of Strongyloides stercoralis in rural Cambodia. PLoS neglected tropical diseases. 2014; 8(6):
e2854. doi: 10.1371/journal.pntd.0002854 PMID: 24921627; PubMed Central PMCID: PMC4055527.
52. Khieu V, Schar F, Marti H, Bless PJ, Char MC, Muth S, et al. Prevalence and risk factors of Strongy-
loides stercoralis in Takeo Province, Cambodia. Parasites & vectors. 2014; 7:221. doi: 10.1186/1756-
3305-7-221 PMID: 24886763; PubMed Central PMCID: PMC4029906.
53. Khieu V, Schar F, Marti H, Sayasone S, Duong S, Muth S, et al. Diagnosis, treatment and risk factors of
Strongyloides stercoralis in schoolchildren in Cambodia. PLoS neglected tropical diseases. 2013; 7(2):
e2035. doi: 10.1371/journal.pntd.0002035 PMID: 23409200; PubMed Central PMCID: PMC3566990.
54. Rim HJ, Chai JY, Min DY, Cho SY, Eom KS, Hong SJ, et al. Prevalence of intestinal parasite infections
on a national scale among primary schoolchildren in Laos. Parasitology research. 2003; 91(4):267–72.
doi: 10.1007/s00436-003-0963-x PMID: 14574555.
55. Greaves D, Coggle S, Pollard C, Aliyu SH, Moore EM. Strongyloides stercoralis infection. Bmj. 2013;
347:f4610. doi: 10.1136/bmj.f4610 PMID: 23900531.
56. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging
global infectious disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;
102(4):314–8. doi: 10.1016/j.trstmh.2008.01.020 PMID: 18321548.
57. Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, et al. Serologic markers for detecting
malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis. 2010; 16(3):392–9. doi: 10.3201/
eid1603.090732 PMID: 20202412; PubMed Central PMCID: PMCPMC3322012.
58. Incardona S, Vong S, Chiv L, Lim P, Nhem S, Sem R, et al. Large-scale malaria survey in Cambodia:
novel insights on species distribution and risk factors. Malaria journal. 2007; 6:37. doi: 10.1186/1475-
2875-6-37 PMID: 17389041; PubMed Central PMCID: PMC1847522.
59. Dysoley L, Kaneko A, Eto H, Mita T, Socheat D, Borkman A, et al. Changing patterns of forest malaria
among the mobile adult male population in Chumkiri District, Cambodia. Acta tropica. 2008; 106
(3):207–12. doi: 10.1016/j.actatropica.2007.01.007 PMID: 18471797.
Parasitic Disease Seroprevalence Among CambodianWomen
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004699 May 3, 2016 16 / 16
